The balance between tumor-infiltrating immune effector cells in the TME (such as CD4+ T cells and CD8+ T cells (or cytotoxic T lymphocytes, CTLs)) regulates the immune response to cytotoxic effects on tumor cells. The gene discussed is CD4; the disease is neoplasm.